Sabrina A. Assoumou, MD MPH, is Assistant Professor of Medicine at Boston University School of Medicine and an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for human immunodeficiency virus (HIV)-infected patients at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.
Dr. Assoumou has published in multiple journals including Clinical Infectious Diseases, AIDS, Annals of Internal Medicine and the Journal of American Medical Association. Her work has also been included in the American Association for the Study of Liver Diseases (AASLD)/ Infectious Diseases Society of America (IDSA) recommendations for testing, managing and treating HCV (Assoumou et al., Clin Infect Dis 2018) as well as HCV testing recommendations by the Centers for Disease Control and Prevention (Assoumou et al., Clin Infect Dis 2018 and Assoumou et al., Clin Infect Dis. 2019). Dr. Assoumou has also presented her findings at the National Academy of Sciences to the panel tasked with developing a National Strategy for the Elimination of Hepatitis B and C and at international scientific meetings such as IDWeek and the Conference on Retroviruses and Opportunistic Infections (CROI).
Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health. Dr. Assoumou received an Excellence in Teaching Hospital-Based Faculty Award at BMC in 2017. She was also recognized as the Distinguished Faculty of the Month in April 2020 for her service to the BUSM community in teaching, service on committees, mentoring of students, trainees and junior faculty.
- University of Rochester School of Medicine & Dentistry, MD
- Harvard School of Public Health, MPH
- Williams College, BA
- Published on 9/2/2020
Assoumou SA, Paniagua SM, Linas BP, Wang J, Samet JH, Hall J, White LF, Beckwith CG. Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial. J Infect Dis. 2020 Sep 02; 222(Supplement_5):S376-S383. PMID: 32877557.
- Published on 7/25/2020
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Jul 25; 99:28-33. PMID: 32721528.
- Published on 6/27/2020
Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. Am J Med. 2020 Jun 27. PMID: 32603791.
- Published on 3/17/2020
Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clin Infect Dis. 2020 Mar 17; 70(7):1388-1396. PMID: 31095676.
- Published on 3/4/2020
Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020 May; 35(5):1477-1483. PMID: 32133577.
- Published on 12/10/2019
Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 12 10; 322(22):2245-2248. PMID: 31821424.
- Published on 2/11/2019
Childs E, Assoumou SA, Biello KB, Biancarelli DL, Drainoni ML, Edeza A, Salhaney P, Mimiaga MJ, Bazzi AR. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019 02 11; 16(1):14. PMID: 30744628.
- Published on 11/19/2018
Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 01; 56(1):8-16. PMID: 30467088.
- Published on 1/18/2018
Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 01 18; 66(3):376-384. PMID: 29020317.
- Published on 1/1/2017
Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344. PMID: 29176099.
View 9 more publications: View full profile at BUMC